{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T06:54:24Z","timestamp":1795071264751,"version":"4.10.2"},"reference-count":72,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,8]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>In this study, we first analyzed data from 147 patients with solitary plasmacytomas treated at the Mayo Clinic between 2005 and 2022 and then expanded our investigation through a systematic review and meta-analysis of 62 studies, encompassing 3487 patients from the years 1960 to 2022. Our findings reveal that patients with up to 10% clonal plasma cells in their bone marrow (BM), denoted as plasmacytoma\u00a0+, had a significantly reduced median disease-free survival (DFS) of 15.7\u00a0months vs 79\u00a0months, P\u00a0&amp;lt; .05, observed in patients with true solitary plasmacytomas, with no clonal cells in the BM. Risk factors identified for shorter DFS included the presence of clonal plasma cells in the marrow and a difference between involved and uninvolved free light chains of &amp;gt;5\u00a0mg\/dL. The meta-analysis portion of our study highlighted a male predominance among patients, with a median age of 58 years, and confirmed radiation therapy as the predominant treatment modality. We also found that DFS rates at 3, 5, and 10 years were 66.9%, 55%, and 42.1%, respectively, and noted a significant difference in outcomes between patients with bone and extramedullary plasmacytomas, with the latter group exhibiting better survival rates. This dual-faceted approach provides a thorough overview of survival rates and critical risk factors for patients with plasmacytoma, underscoring the vital role of accurate disease staging at diagnosis and the impact of tumor location on patient prognosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024013355","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T21:56:02Z","timestamp":1738274162000},"page":"1559-1570","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":23,"title":["Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes"],"prefix":"10.1182","volume":"9","author":[{"given":"Charalampos","family":"Charalampous","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2638-5773","authenticated-orcid":false,"given":"Jean-Sebastien","family":"Claveau","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-9658","authenticated-orcid":false,"given":"Moritz","family":"Binder","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3214-0203","authenticated-orcid":false,"given":"Francis K.","family":"Buadi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5335-9533","authenticated-orcid":false,"given":"Joselle","family":"Cook","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dingli","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-9512","authenticated-orcid":false,"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9488-8212","authenticated-orcid":false,"given":"Amie L.","family":"Fonder","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3853-5196","authenticated-orcid":false,"given":"Morie A.","family":"Gertz","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Gonsalves","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne R.","family":"Hayman","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam A.","family":"Hobbs","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi L.","family":"Hwa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8573-9434","authenticated-orcid":false,"given":"Taxiarchis","family":"Kourelis","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1193-1559","authenticated-orcid":false,"given":"Martha Q.","family":"Lacy","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5651-1411","authenticated-orcid":false,"given":"Nelson","family":"Leung","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0240-0326","authenticated-orcid":false,"given":"Rahma","family":"Warsame","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-9284","authenticated-orcid":false,"given":"Shaji K.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"6","key":"2025040813163348300_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2141.2004.04834.x","article-title":"Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma","volume":"124","author":"Soutar","year":"2004","journal-title":"Br J Haematol"},{"issue":"1","key":"2025040813163348300_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.2008.07421.x","article-title":"Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004","volume":"144","author":"Dores","year":"2009","journal-title":"Br J Haematol"},{"issue":"12","key":"2025040813163348300_bib3","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"1","key":"2025040813163348300_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0360-3016(89)90008-4","article-title":"Solitary plasmacytoma of bone: Mayo Clinic experience","volume":"16","author":"Frassica","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"2025040813163348300_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ajh.23201","article-title":"Trends and outcomes of modern staging of solitary plasmacytoma of bone","volume":"87","author":"Warsame","year":"2012","journal-title":"Am J Hematol"},{"issue":"7","key":"2025040813163348300_bib6","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"2025040813163348300_bib7","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Deeks","year":"2011","edition":"2nd ed"},{"issue":"7303","key":"2025040813163348300_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ (Clinical research ed)"},{"key":"2025040813163348300_bib9","unstructured":"R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2022. Accessed 17 February 2025. https:\/\/www.R-project.org\/."},{"issue":"5","key":"2025040813163348300_bib10","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.7861\/clinmed.2019-0488","article-title":"Clinical presentation and outcomes of solitary plasmacytoma in a tertiary hospital in the UK","volume":"20","author":"Agbuduwe","year":"2020","journal-title":"Clin Med"},{"issue":"1","key":"2025040813163348300_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00259-017-3810-5","article-title":"18F\u2013FDG PET\/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma","volume":"45","author":"Albano","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"2025040813163348300_bib12","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00432-020-03452-y","article-title":"Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience","volume":"147","author":"Alghisi","year":"2021","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"S 01","key":"2025040813163348300_bib13","first-page":"S1","article-title":"Single-center experience of solitary bone plasmacytoma of the vertebral column in comparison with extramedullary plasmacytoma of the skull base","volume":"79","author":"Ali","year":"2018","journal-title":"J\u00a0Neurol Surg B"},{"issue":"8","key":"2025040813163348300_bib14","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3109\/10428194.2012.750725","article-title":"Solitary plasmacytoma: 10 years' experience at All India Institute of Medical Sciences, New Delhi","volume":"54","author":"Baghmar","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2025040813163348300_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hon.2415","article-title":"Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: a population-based, single-center study with median follow-up of 13.7 years","volume":"36","author":"Barzenje","year":"2018","journal-title":"Hematol Oncol"},{"issue":"1","key":"2025040813163348300_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-5223(19)33852-8","article-title":"Medical tumors of the chest wall. Solitary plasmacytoma and Ewing's sarcoma","volume":"105","author":"Burt","year":"1993","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"2","key":"2025040813163348300_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3857\/roj.2019.00570","article-title":"The predictive value of serum myeloma protein in solitary plasmacytoma","volume":"38","author":"Chang","year":"2020","journal-title":"Radiat Oncol J"},{"issue":"suppl 10","key":"2025040813163348300_bib18","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1016\/j.clml.2019.09.506","article-title":"Impact of tumor size and minimal marrow involvement on outcomes of patients with solitary plasmacytoma","volume":"19","author":"Chinen","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"2025040813163348300_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF03168516","article-title":"Solitary plasmacytoma: experiences from Central Anatolia","volume":"174","author":"Coskun","year":"2005","journal-title":"Ir J Med Sci"},{"issue":"10","key":"2025040813163348300_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/COC.0000000000000734","article-title":"Long-term outcomes after definitive radiation therapy for solitary plasmacytoma","volume":"43","author":"Curry","year":"2020","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"2025040813163348300_bib21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.14291","article-title":"Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands","volume":"175","author":"de Waal","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"2025040813163348300_bib22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/cancers12030676","article-title":"Maximizing the clinical benefit of radiotherapy in solitary plasmacytoma: an international multicenter analysis","volume":"12","author":"Elsayad","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2025040813163348300_bib23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/bjh.13870","article-title":"Clinical features and prognostic factors in solitary plasmacytoma","volume":"172","author":"Finsinger","year":"2016","journal-title":"Br J Haematol"},{"issue":"12","key":"2025040813163348300_bib24","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1158\/1078-0432.CCR-13-2910","article-title":"Impact of initial FDG-PET\/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma","volume":"20","author":"Fouquet","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"suppl 1","key":"2025040813163348300_bib25","doi-asserted-by":"crossref","first-page":"10104","DOI":"10.1182\/blood-2022-169633","article-title":"Predictors of response to radiation therapy and of progression to multiple myeloma in patients with solitary bone and extramedullary plasmacytomas","volume":"140","author":"Fregonese","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2025040813163348300_bib26","first-page":"47","article-title":"Clinical outcome of extramedullary plasmacytoma","volume":"85","author":"Galieni","year":"2000","journal-title":"Haematologica"},{"issue":"14","key":"2025040813163348300_bib27","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1080\/10428194.2022.2118535","article-title":"Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas: a report of the Israeli Myeloma Study Group","volume":"63","author":"Ganzel","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"2025040813163348300_bib28","first-page":"1659","article-title":"Prognostic factors associated with solitary plasmacytoma","volume":"6","author":"Guo","year":"2013","journal-title":"Onco Targets Ther"},{"issue":"6","key":"2025040813163348300_bib29","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/1097-0142(19920315)69:6<1513::AID-CNCR2820690633>3.0.CO;2-X","article-title":"Plasmacytoma. Treatment results and conversion to myeloma","volume":"69","author":"Holland","year":"1992","journal-title":"Cancer"},{"issue":"833","key":"2025040813163348300_bib30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1259\/bjr.70.833.9227234","article-title":"Radiotherapy in the treatment of solitary plasmacytoma","volume":"70","author":"Jyothirmayi","year":"1997","journal-title":"Br J Radiol"},{"issue":"8","key":"2025040813163348300_bib31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ajh.23745","article-title":"Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek Myeloma Study Group in 97 patients","volume":"89","author":"Katodritou","year":"2014","journal-title":"Am J Hematol"},{"key":"2025040813163348300_bib32","doi-asserted-by":"crossref","first-page":"895765","DOI":"10.1100\/2012\/895765","article-title":"A\u00a0review for solitary plasmacytoma of bone and extramedullary plasmacytoma","volume":"2012","author":"Kilciksiz","year":"2012","journal-title":"Sci World J"},{"issue":"suppl 1","key":"2025040813163348300_bib33","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1016\/S2152-2650(21)01974-1","article-title":"Factors of an unfavorable prognosis in patients with solitary plasmacytoma among residents of the Gomel region of Belarus [abstract]","volume":"21","author":"Kozich","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"9","key":"2025040813163348300_bib34","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.7314\/APJCP.2015.16.9.3741","article-title":"Radiotherapy alone is associated with improved outcomes over surgery in the management of solitary plasmacytoma","volume":"16","author":"Li","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"issue":"22","key":"2025040813163348300_bib35","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood.V114.22.1806.1806","article-title":"Molecular profiling of extramedullary and medullary plasmacytomas","volume":"114","author":"Mahindra","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2025040813163348300_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41408-021-00419-1","article-title":"Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up","volume":"11","author":"Manasanch","year":"2021","journal-title":"Blood Cancer J"},{"issue":"3","key":"2025040813163348300_bib37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijrobp.2019.10.043","article-title":"Solitary plasmacytoma treated by lenalidomide-dexamethasone in combination with radiation therapy: clinical outcomes","volume":"106","author":"Mignot","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2025040813163348300_bib38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/ejh.12907","article-title":"Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish myeloma register","volume":"99","author":"Nahi","year":"2017","journal-title":"Eur J Haematol"},{"issue":"5","key":"2025040813163348300_bib39","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s12185-020-02961-3","article-title":"Retrospective analysis of plasmacytoma in Kansai Myeloma Forum registry","volume":"112","author":"Nakaya","year":"2020","journal-title":"Int J Hematol"},{"issue":"1","key":"2025040813163348300_bib40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijrobp.2005.06.039","article-title":"Outcomes and patterns of failure in solitary plasmacytoma: a multicenter rare cancer network study of 258 patients","volume":"64","author":"Ozsahin","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"2025040813163348300_bib41","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1182\/blood-2014-04-567909","article-title":"Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma","volume":"124","author":"Paiva","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2025040813163348300_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/106689699900700407","article-title":"A\u00a0clinicopathologic study of solitary myeloma: an 11-year study","volume":"7","author":"Sariya","year":"1999","journal-title":"Int J Surg Pathol"},{"issue":"7","key":"2025040813163348300_bib43","doi-asserted-by":"crossref","first-page":"e0219857","DOI":"10.1371\/journal.pone.0219857","article-title":"Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era","volume":"14","author":"Sharpley","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"2025040813163348300_bib44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/bjc.1995.26","article-title":"Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone","volume":"71","author":"Shih","year":"1995","journal-title":"Br J Cancer"},{"issue":"11","key":"2025040813163348300_bib45","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00277-012-1510-6","article-title":"Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors","volume":"91","author":"Suh","year":"2012","journal-title":"Ann Hematol"},{"issue":"4","key":"2025040813163348300_bib46","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2018.05.009","article-title":"Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the International Lymphoma Radiation Oncology Group","volume":"101","author":"Tsang","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025040813163348300_bib47","author":"Velazquez Kennedy","year":"18  2017"},{"issue":"1","key":"2025040813163348300_bib48","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1186\/s12885-019-5976-7","article-title":"Clinicopathological spectrum of solitary plasmacytoma: a single center experience from coastal India","volume":"19","author":"Basavaiah","year":"2019","journal-title":"BMC Cancer"},{"issue":"8","key":"2025040813163348300_bib49","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hed.20821","article-title":"Solitary extramedullary plasmacytoma of the head and neck\u2014long-term outcome analysis of 68 cases","volume":"30","author":"Bachar","year":"2008","journal-title":"Head Neck"},{"issue":"4","key":"2025040813163348300_bib50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1445-5994.2005.00804.x","article-title":"Radiotherapy in the management of solitary extramedullary plasmacytoma","volume":"35","author":"Chao","year":"2005","journal-title":"Intern Med J"},{"issue":"1","key":"2025040813163348300_bib51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13014-019-1265-5","article-title":"Impact of radiation dose on local control and survival in extramedullary head and neck plasmacytoma","volume":"14","author":"Oertel","year":"2019","journal-title":"Radiat Oncol"},{"issue":"2","key":"2025040813163348300_bib52","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ijrobp.2010.11.037","article-title":"Multi-institutional analysis of solitary extramedullary plasmacytoma of the head and neck treated with curative radiotherapy","volume":"82","author":"Sasaki","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2025040813163348300_bib53","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hon.2261","article-title":"Effect of definitive radiotherapy on the long-term outcome in patients with solitary extramedullary plasmacytoma","volume":"35","author":"Sk\u00f3ra","year":"2017","journal-title":"Hematol Oncol"},{"issue":"3","key":"2025040813163348300_bib54","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0360-3016(02)02780-3","article-title":"Extramedullary plasmacytoma: clinical and histopathologic study","volume":"53","author":"Strojan","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2025040813163348300_bib55","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/bjc.1997.162","article-title":"Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 cases","volume":"75","author":"Susnerwala","year":"1997","journal-title":"Br J Cancer"},{"issue":"5","key":"2025040813163348300_bib56","doi-asserted-by":"crossref","first-page":"438","DOI":"10.21147\/j.issn.1000-9604.2017.05.08","article-title":"Management of extramedullary plasmacytoma: role of radiotherapy and prognostic factor analysis in 55 patients","volume":"29","author":"Wen","year":"2017","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"2025040813163348300_bib57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0145561320950587","article-title":"Extramedullary plasmacytoma: long-term clinical outcomes in a single-center in China and literature review","volume":"100","author":"Zhu","year":"2021","journal-title":"Ear Nose Throat J"},{"issue":"1","key":"2025040813163348300_bib58","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1186\/s12885-016-2824-x","article-title":"Establishment of an innovative staging system for extramedullary plasmacytoma","volume":"16","author":"Zhu","year":"2016","journal-title":"BMC Cancer"},{"issue":"8","key":"2025040813163348300_bib59","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1097\/RLU.0000000000000819","article-title":"18F-FDG PET\/CT for early postradiotherapy assessment in solitary bone plasmacytomas","volume":"40","author":"Alongi","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"suppl 1","key":"2025040813163348300_bib60","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1136\/annrheumdis-2022-eular.3718","article-title":"Characteristics, outcome and factors associated with evolution to multiple myeloma and survival in patients with solitary bone plasmacytoma [abstract]","volume":"81","author":"Ascione","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2025040813163348300_bib61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1099-1069(199609)14:3<111::AID-HON575>3.0.CO;2-G","article-title":"Improved outcome in solitary bone plasmacytomata with combined therapy","volume":"14","author":"Avil\u00e9s","year":"1996","journal-title":"Hematol Oncol"},{"issue":"2","key":"2025040813163348300_bib62","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1016\/j.ijrobp.2017.06.1623","article-title":"Long-term outcomes in patients with solitary bone plasmacytoma treated with definitive radiation therapy","volume":"99","author":"Bacorro","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl 1","key":"2025040813163348300_bib63","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1182\/blood-2021-145024","article-title":"The analysis of risk for solitary bone plasmacytoma rapidly progressing to multiple myeloma","volume":"138","author":"Chen","year":"2021","journal-title":"Blood"},{"issue":"6","key":"2025040813163348300_bib64","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1182\/blood-2006-04-015784","article-title":"Immunoglobulin free light chains and solitary plasmacytoma of bone","volume":"108","author":"Dingli","year":"2006","journal-title":"Blood"},{"issue":"8","key":"2025040813163348300_bib65","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1097\/BRS.0b013e3181c9b431","article-title":"Solitary plasmacytoma of cervical spine: treatment and prognosis in patients with neurological lesions and spinal instability","volume":"35","author":"Huang","year":"2010","journal-title":"Spine"},{"issue":"3","key":"2025040813163348300_bib66","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.rpor.2020.04.002","article-title":"Impact of bone events on survival in solitary bone plasmacytoma","volume":"25","author":"Mauro","year":"2020","journal-title":"Rep Pract Oncol Radiother"},{"issue":"11","key":"2025040813163348300_bib67","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1080\/10428194.2019.1605067","article-title":"New insights in the treatment of patients with solitary bone plasmacytoma","volume":"60","author":"Mheidly","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2025040813163348300_bib68","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.spinee.2019.09.018","article-title":"Reossification and prognosis following radiotherapy with\/without surgery for spinal solitary plasmacytoma of the bone: a retrospective study of 39 patients","volume":"20","author":"Ouyang","year":"2020","journal-title":"Spine J"},{"issue":"5","key":"2025040813163348300_bib69","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.10366","article-title":"Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone","volume":"94","author":"Wilder","year":"2002","journal-title":"Cancer"},{"issue":"8","key":"2025040813163348300_bib70","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1182\/blood-2014-04-566521","article-title":"Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis","volume":"124","author":"Hill","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2025040813163348300_bib71","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1182\/blood-2014-04-566521","article-title":"Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis","volume":"124","author":"Hill","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2025040813163348300_bib72","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41375-018-0099-8","article-title":"Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset","volume":"32","author":"Goyal","year":"2018","journal-title":"Leukemia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/7\/1559\/2362789\/blooda_adv-2024-013355-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/7\/1559\/2362789\/blooda_adv-2024-013355-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T13:18:20Z","timestamp":1744118300000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/7\/1559\/535369\/Solitary-plasmacytoma-single-institution"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":72,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,4,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024013355","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}